Compare WuXi AppTec Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 16.30%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 43.26
3
Healthy long term growth as Net Sales has grown by an annual rate of 22.18% and Operating profit at 40.10%
4
Flat results in Dec 18
5
With ROE of 25.75%, it has a Fair valuation with a 0.64 Price to Book Value
6
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
HKD 50,384 Million ()
2.00
NA
0.00%
-0.14
23.61%
0.65
Revenue and Profits:
Net Sales:
13,161 Million
(Quarterly Results - Sep 2025)
Net Profit:
3,877 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.77%
0%
19.77%
6 Months
17.1%
0%
17.1%
1 Year
102.09%
0%
102.09%
2 Years
208.82%
0%
208.82%
3 Years
40.0%
0%
40.0%
4 Years
20.46%
0%
20.46%
5 Years
-28.21%
0%
-28.21%
WuXi AppTec Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.18%
EBIT Growth (5y)
40.10%
EBIT to Interest (avg)
43.26
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.66
Tax Ratio
14.88%
Dividend Payout Ratio
30.07%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
19.62%
ROE (avg)
16.30%
Valuation key factors
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.64
EV to EBIT
1.78
EV to EBITDA
1.78
EV to Capital Employed
0.53
EV to Sales
0.59
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
29.50%
ROE (Latest)
25.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
13,161.00
12,026.00
9.44%
Operating Profit (PBDIT) excl Other Income
5,046.50
5,129.20
-1.61%
Interest
97.00
95.60
1.46%
Exceptional Items
-87.40
-209.60
58.30%
Consolidate Net Profit
3,876.60
5,185.50
-25.24%
Operating Profit Margin (Excl OI)
383.40%
349.10%
3.43%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.44% vs 16.50% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -25.24% vs 35.54% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
41,111.40
42,739.10
-3.81%
Operating Profit (PBDIT) excl Other Income
15,407.10
15,056.30
2.33%
Interest
256.00
174.20
46.96%
Exceptional Items
83.00
-96.40
186.10%
Consolidate Net Profit
12,249.60
12,533.10
-2.26%
Operating Profit Margin (Excl OI)
301.40%
293.30%
0.81%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -3.81% vs -6.61% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -2.26% vs 21.10% in Dec 2023
About WuXi AppTec Co., Ltd. 
WuXi AppTec Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






